1742P Factors influencing awareness of patient associations in sarcoma: A multicentric cross-sectional study von Mascaró Baselga, P., Villacampa, G., Navarro Garces, V., Sebio Garcia, A., Alvarez, R.M., Sala Gonzalez, M.A., Marquina Ospina, G., Martinez Trufero, J., Cano, J.M., Redondo, A., Molina Diaz, A., Vega Cano, K.S., Salva de Torres, C., Yaringaño Cerna, J.G., Martínez-Albaladejo, P., de Torner Vidal, A., Cicala, C.M., Tabernero, J., Valverde Morales, C.M., Serrano, C.

Volltext

2137P Impact of supportive care on the quality of life (QoL) of hospitalized cancer patients (pts) von Beltran, J. Sanz, Mirallas, O., Bosma, F., Pérez, M.A. Molina, Salva, C., Cano, K.S. Vega, Puerto, D.A. Gomez, Valbuena, D.E. López, Hermida, J.M. Ucha, Lores, G. Molina, Herrera, M. Roca, Sahun, C. Sola, Montenegro, D. Romero, Serradell, S., Paez, D., Galceran, J. Carles, Cullell, B. Martin

Volltext

473P Predictive factors for drug-induced liver injury in patients with ER-positive HER2-negative metastatic breast cancer treated with first-line cyclin-dependent kinase 4/6 inhibi... von Cano, K.S. Vega, Javierre, G. Villacampa, Baselga, P. Mascaró, Mirallas, O., Adelantado, E. Zamora, Gomez, L. Sanz, Ortiz, C., Lapena, M. Cruellas, Arumi de Dios, M., Puy, M. Borrell, Filippi-Arriaga, F., Joval, L., Yaringaño, J.G., Martínez-Albaladejo, P., Buch, P.B., Esteban, P., Ruiz-Ortega, L., Manich, C. Saura, Riveiro-Barciela, M., Ezquerra, M. Bellet

Volltext

2144P The PRognostic Oncologic Plantology (PROP) website tool predicts 30-day mortality in hospitalized cancer patients on treatment von Mirallas, O., Cullell, B. Martin, Navarro, V., Pedrola, A., Cano, K.S. Vega, Recuero-Borau, J., Salva, C., Valbuena, D.E. López, Puerto, D.A. Gomez, Beltran, J. Sanz, Hermida, J.M. Ucha, Lores, G. Molina, Roca, M., Saiz, A. Peñuelas, Serradell, S., Tabernero, J., Tormo, S. Servitja, Paez, D., Dienstmann, R., Galceran, J. Carles

Volltext

87P EPClin vs OncotypeDx in invasive lobular cancer (ILC) von Leao, I., Zamora, E., Gomez Pardo, P., Arumi de Dios, M.A., Pimentel, I., Escriva de Romani, S., Ortiz Velez, C., Cruellas Lapena, M., Sanz, L., Borrell, M., Vega Cano, K.S., Gómez-Puerto, D., De La Torre, J., Espinosa-Bravo, M., Oliveira, M., Fasani, R., Nuciforo, P.G., Saura, C., Peg, V., Bellet, M.

Volltext

166P Clinical use of tumor sequencing for identification of germline pathogenic variants (gPV) in breast cancer (BC): The SEQ project von Lapena, M. Cruellas, Papakonstantinou, A., Castillo, E., Rezqallah Aron, M.A., Torres, M., Cano, K.S. Vega, Matito, J., Gómez, M., Garces, V. Navarro, Manich, C. Saura, Vivancos, A., Oliveira, M., Balmaña, J.

Volltext

29O Clinical characterization of long-term survivors in phase I clinical trials von Mirallas, O., Rossi, A., Fernández, E.M., Garcia-Galea, E., Cano, K.S. Vega, Moya, J. Ginard, Calvo, A. Hernando, Pretelli, G., Bardaji, M.J. Lostes, Oberoi, A., Galvao, V., Laimito, K.I. Rojas, Morillo, B. Ortega, Casal, G. Alonso, Izquierdo, S. Aguilar, Braña, I., Dienstmann, R., Villar, M. Vieito, Garralda, E.

Volltext

115P Longterm prognostic utility of 70-gene signature by clinical and genomic risks, including Ultralow (gUL) risk patients (pts) von Gomez, L. Sanz, Zamora, E., Joval, L., Velez, C. Ortiz, Puy, M. Borrell, Arumi de Dios, M.A., Puerto, D.A. Gomez, Garces, V. Navarro, Rezqallah Aron, M.A., Cano, K.S. Vega, Escrivá-De-Romaní, S., Mirallas, O., Pimentel, I., Lapena, M. Cruellas, Villacampa, G., Oliveira, M., Manich, C. Saura, Pardo, P. Gomez, Cámara, V. Peg, Bellet-Ezquerra, M.

Volltext

250P Liver Toxicity (LT) in patients (pts) with ER-positive HER2-negative metastatic breast cancer (MBC) treated with first-line Cyclin-Dependent Kinase 4/6 inhibitors (CDKi) von Cano, K.S. Vega, Mascaro, P., Mirallas, O., Filippi-Arriaga, F., Joval, L., Zamora, E., Gomez, L. Sanz, Velez, C. Ortiz, Lapena, M. Cruellas, Arumi de Dios, M.A., Puy, M. Borrell, Esteban, P., Ruiz-Ortega, L., Buch, P.B., Yaringaño, J., Lores, G. Molina, Gomez-Puerto, D., Manich, C. Saura, Riveiro-Barciela, M., Bellet-Ezquerra, M.

Volltext